NCT03030729View on ClinicalTrials.gov

Macular Thickness Measurements Using Retinal-thickness OCT

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

March 14, 2017

Primary Completion Date

January 14, 2018

Study Completion Date

January 14, 2018

Conditions
Age-Related Macular DegenerationDiabetic Retinopathy
Trial Locations (1)

Unknown

Sorasky Medical Center, Tel Aviv

Sponsors

Lead Sponsor

Notal Vision Ltd.
All Listed Sponsors
lead

Notal Vision Ltd.

INDUSTRY

NCT03030729 - Macular Thickness Measurements Using Retinal-thickness OCT | Biotech Hunter | Biotech Hunter